Scholarlink

Introduction <p>The rising prevalence of obesity among the elderly poses unique challenges. While life expectancy has improved due to advancements in medical care, this increase in longevity does not necessarily correlate with an improved quality of life. Instead, the obesity epidemic, particularly in the later decades of life, is linked to a heightened demand for healthcare services and higher healthcare costs. This study aimed to analyze bariatric surgeons’ perspectives on the role of anti-obesity medications (AOMs) in metabolic bariatric surgery (MBS) for patients over 65, focusing on treatment preferences in clinical scenarios. Additionally, an obesity treatment algorithm for older patients was proposed.</p> Material and Methods <p>A survey was conducted among bariatric surgeons worldwide from September to October 2024, including questions on demographics, experience, and clinical scenarios. A questionnaire specifically designed for the purposes of this study was used.</p> Results <p>Of 184 respondents from 53 countries, 77.2% reported prescribing AOMs. Sleeve gastrectomy is most preferred as the primary surgical option for patients over 65. Treatment preferences varied by <i>BMI</i>, with AOMs favored for a <i>BMI</i> of 30–35&#xa0;kg/m<sup>2</sup>, and MBS preferred for higher <i>BMI</i>s.</p> Conclusions <p>This study highlights the integration of AOMs into obesity management for older adults, with sleeve gastrectomy as the primary surgical choice. Treatment choices were consistent across surgeon demographics, underscoring the need for tailored approaches in elderly obesity care.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Obesity Solutions for Patients over 65 Years of Age: Surgeon Perspectives on Anti-obesity Medications and Metabolic Bariatric Surgery — International Survey Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月17日

查看全文
  • Natalia Dowgiałło-Gornowicz,
  • Mateusz Wityk,
  • Paweł Jaworski,
  • Paweł Lech,
  • Chetan Parmar

摘要

Introduction

The rising prevalence of obesity among the elderly poses unique challenges. While life expectancy has improved due to advancements in medical care, this increase in longevity does not necessarily correlate with an improved quality of life. Instead, the obesity epidemic, particularly in the later decades of life, is linked to a heightened demand for healthcare services and higher healthcare costs. This study aimed to analyze bariatric surgeons’ perspectives on the role of anti-obesity medications (AOMs) in metabolic bariatric surgery (MBS) for patients over 65, focusing on treatment preferences in clinical scenarios. Additionally, an obesity treatment algorithm for older patients was proposed.

Material and Methods

A survey was conducted among bariatric surgeons worldwide from September to October 2024, including questions on demographics, experience, and clinical scenarios. A questionnaire specifically designed for the purposes of this study was used.

Results

Of 184 respondents from 53 countries, 77.2% reported prescribing AOMs. Sleeve gastrectomy is most preferred as the primary surgical option for patients over 65. Treatment preferences varied by BMI, with AOMs favored for a BMI of 30–35 kg/m2, and MBS preferred for higher BMIs.

Conclusions

This study highlights the integration of AOMs into obesity management for older adults, with sleeve gastrectomy as the primary surgical choice. Treatment choices were consistent across surgeon demographics, underscoring the need for tailored approaches in elderly obesity care.